Sinovac Biotech Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS12
PHASE 3 / 2-310
RECRUITING6
READOUTS ≤12 MONTHS7
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| bivalent enterovirus vaccine (Vero cell), inactivated NCT06734832 |
P3 | Recruiting | Hand, Foot, and Mouth Disease(HFMD) | 8000 | 2025-11-30 |
| Rabies Vaccine (Serum-free Vero Cell), Freeze-dried NCT07055880 |
P2 | Not yet recruiting | Rabies | 120 | 2026-01-15 |
| Low-dose experimental vaccine NCT07400003 |
P1/2 | Recruiting | Herpes Zoster; mRNA Vaccine | 519 | 2026-05-31 |
| Sinovac rabies vaccine NCT07416110 |
P3 | Active, not recruiting | Rabies (Healthy Volunteers) | 912 | 2026-07-15 |
| experimental vaccine NCT07505888 |
P3 | Active, not recruiting | Epidemic Meningitis; Meningococcal Vaccines | 660 | 2026-11 |
| Rabies Vaccine (Serum-free Vero Cell), Freeze-dried NCT07055295 |
P3 | Not yet recruiting | Rabies | 390 | 2026-12-30 |
| experimental vaccine NCT07505836 |
P3 | Recruiting | Epidemic Meningitis; Meningococcal Vaccines | 1040 | 2027-01 |
| Rabies vaccine NCT07055893 |
P3 | Not yet recruiting | Rabies (Healthy Volunteers) | 390 | 2027-01-30 |
| experimental vaccine NCT07505810 |
P3 | Recruiting | Epidemic Meningitis; Meningococcal Vaccines | 880 | 2027-04 |
| experimental vaccine NCT07505823 |
P3 | Recruiting | Epidemic Meningitis; Meningococcal Vaccines | 1040 | 2027-04 |
| Inactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL) NCT07793227 |
P3 | Recruiting | Hepatitis A Vaccine | 680 | 2027-09-15 |
| Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) NCT07611513 |
P3 | Not yet recruiting | Hand, Foot, and Mouth Disease(HFMD); Herpangina | 6000 | 2027-12 |